DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▲ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0678222 | Breast Carcinoma | ST6GALNAC2 | 10610 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 | Q9UJ37 |
C0206682 | Follicular thyroid carcinoma | ST6GALNAC2 | 10610 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 | Q9UJ37 |
C1269683 | Major Depressive Disorder | ST6GALNAC2 | 10610 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 | Q9UJ37 |
C1306459 | Primary malignant neoplasm | ST6GALNAC2 | 10610 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 | Q9UJ37 |
C0600139 | Prostate carcinoma | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0085207 | Gestational Diabetes | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0376358 | Malignant neoplasm of prostate | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0027651 | Neoplasms | ST6GALNAC4 | 27090 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 | Q9H4F1 |
C0206682 | Follicular thyroid carcinoma | ST6GALNAC4 | 27090 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 | Q9H4F1 |
C0018378 | Guillain-Barre Syndrome | ST6GALNAC4 | 27090 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 | Q9H4F1 |
C0003873 | Rheumatoid Arthritis | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C1956346 | Coronary Artery Disease | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0010054 | Coronary Arteriosclerosis | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0006826 | Malignant Neoplasms | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0027651 | Neoplasms | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0007867 | Cervix Diseases | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0024299 | Lymphoma | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0006142 | Malignant neoplasm of breast | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0010068 | Coronary heart disease | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C1306459 | Primary malignant neoplasm | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0017638 | Glioma | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0007847 | Malignant tumor of cervix | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C0206708 | Cervical Intraepithelial Neoplasia | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024